Featured Article

Scientists have identified a biomarker for Crohn´s disease that also participates in its pathogenesis and occurs years before the disease shows its full clinical spectrum.

Precision Oncology Today

Magazine

Circulating Tumor DNA is Increasingly Effective in Cancer Healthcare

The complexity of cancer can only be better understood and treated with a complex array of tools. In one case, cancer scientists use a single approach—circulating tumor DNA (ctDNA)—in many ways. Plus, even more uses of ctDNA lie ahead.
cancer

MRD: The Future Foundation of Solid Tumor Trials

The terms minimal residual disease, measurable residual disease, and molecular residual disease, interchangeably referred to as MRD, denote what is left after cancer treatment with curative intent. Originally used to monitor patients with hematologic malignancies, MRD is becoming increasingly important in the field of solid tumor oncology because of its correlation with disease outcomes.
digital heads

Relatively Speaking: Unexpected Detours, Can Inconclusive Prenatal Genetic Tests Save Lives?

Uncertain genetic testing results are not an unusual event in the field of genetic counseling. Obstetricians routinely refer patients to genetic counselors to help them navigate unclear prenatal genetic testing results by reviewing the complexities of genetic information and discussing the benefits, risks, and limitations of additional testing.

Trending on Inside Precision Medicine

elderly man with head breaking apart to symbolise dementia or Alzheimer's disease

People At High Genetic Risk for Dementia Also Benefit from Lifestyle Changes

People in the highest category of genetic risk for dementia can reduce risks by making seven beneficial lifestyle changes, say researchers.
cancer

FDA Grants Seribantumab Fast Track Designation for Tumors with NRG1 Gene Fusions

Seribantumab is a fully human IgG2 monoclonal antibody that binds to human epidermal growth factor receptor 3 (HER3).
Diseased colon, illustration to indicate Crohn's disease

Blood Biomarker Predicts Severe Crohn’s Disease Years Before Diagnosis

Scientists have identified a biomarker for Crohn´s disease that also participates in its pathogenesis and occurs years before the disease shows its full clinical spectrum.

Daily News

Trending